In current deal-making, "if it touches China, the likelihood of interest goes down materially." Boards are conducting deep diligence to ensure zero dependency on China. This capital starvation will stifle growth and exit opportunities for companies with Chinese exposure. AVOID. The geopolitical risk premium is effectively infinite for M&A right now. Thaw in US-China relations (unlikely in current context).